Details Basic Details Status Ongoing Last Updated Monday, March 4, 2019 Original Posting Date Monday, March 4, 2019 Health Outcome(s) renal cell carcinoma Purpose Drug and Outcome Analysis Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR Yes Regulatory Link(s) (1) Efficacy Supplement Approval Letter